Apellis Pharmaceuticals, Inc. Common Stock — Chart, Price & News (NASDAQ:APLS) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Market Capitalization 5.25 B
Employee 733
Founded 2009
CEO N/A
Website www.apellis.com
Headquarter Delaware, United States
FIGI BBG007KGRPY4
Industry Biotechnology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

Price to earnings ratio

125.6

Price to sales ratio

3.25

News

Stock Market Today: Nasdaq Charges Higher; Hot Nvidia Rival Surges On Debut (Live Coverage)

Compared to Estimates, Apellis Pharmaceuticals (APLS) Q1 Earnings: A Look at Key Metrics

Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates

Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone

Top 3 Health Care Stocks That May Collapse This Month - Apellis Pharmaceuticals (NASDAQ:APLS), Avanos Med

ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: Should You Buy?

Biogen Beats Q1 Earnings Estimates but Cuts 2026 EPS View on M&A Costs

Apellis Pharmaceuticals, Inc. (APLS) Expected to Beat Earnings Estimates: Should You Buy?

Biogen Walloped Wall Street's First Quarter Views; Here's What Happened

Biogen Q1 Earnings: Can New Launches Offset Declining MS Franchise?

OCGN's Gene-Agnostic Strategy Could Reset Retinal Therapy

OCGN's Gene-Agnostic Strategy Could Reset Retinal Therapy